By Adam Rhodes ( May 8, 2019, 5:38 PM EDT) -- Swiss pharmaceutical company Novartis is mulling making an offer for Takeda's newly acquired eye-disease assets, Bloomberg reported early Wednesday. The assets, which Takeda snapped up in its deal for Shire PLC, could be worth $3.5 billion to $4 billion, according to the report. However, the report said a final decision on a deal has not been made....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.